FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378981004> ?p ?o ?g. }

• W4378981004 abstract "<div>AbstractPurpose:<p>No evidence exists as to whether type 2 diabetes mellitus (T2DM) impairs clinical outcome from immune checkpoint inhibitors (ICI) in patients with solid tumors.</p>Experimental Design:<p>In a large cohort of ICI recipients treated at 21 institutions from June 2014 to June 2020, we studied whether patients on glucose-lowering medications (GLM) for T2DM had shorter overall survival (OS) and progression-free survival (PFS). We used targeted transcriptomics in a subset of patients to explore differences in the tumor microenvironment (TME) of patients with or without diabetes.</p>Results:<p>A total of 1,395 patients were included. Primary tumors included non–small cell lung cancer (NSCLC; 54.7%), melanoma (24.7%), renal cell (15.0%), and other carcinomas (5.6%). After multivariable analysis, patients on GLM (<i>n</i> = 226, 16.2%) displayed an increased risk of death [HR, 1.29; 95% confidence interval (CI),1.07–1.56] and disease progression/death (HR, 1.21; 95% CI, 1.03–1.43) independent of number of GLM received. We matched 92 metformin-exposed patients with 363 controls and 78 patients on other oral GLM or insulin with 299 control patients. Exposure to metformin, but not other GLM, was associated with an increased risk of death (HR, 1.53; 95% CI, 1.16–2.03) and disease progression/death (HR, 1.34; 95% CI, 1.04–1.72). Patients with T2DM with higher pretreatment glycemia had higher neutrophil-to-lymphocyte ratio (<i>P</i> = 0.04), while exploratory tumoral transcriptomic profiling in a subset of patients (<i>n</i> = 22) revealed differential regulation of innate and adaptive immune pathways in patients with T2DM.</p>Conclusions:<p>In this study, patients on GLM experienced worse outcomes from immunotherapy, independent of baseline features. Prospective studies are warranted to clarify the relative impact of metformin over a preexisting diagnosis of T2DM in influencing poorer outcomes in this population.</p></div>" @default.
• W4378981004 created "2023-06-02" @default.
• W4378981004 creator A5001343667 @default.
• W4378981004 creator A5004680827 @default.
• W4378981004 creator A5005250000 @default.
• W4378981004 creator A5007787317 @default.
• W4378981004 creator A5008719596 @default.
• W4378981004 creator A5008736570 @default.
• W4378981004 creator A5008894786 @default.
• W4378981004 creator A5011850347 @default.
• W4378981004 creator A5012176145 @default.
• W4378981004 creator A5013768705 @default.
• W4378981004 creator A5013913173 @default.
• W4378981004 creator A5016688954 @default.
• W4378981004 creator A5016711314 @default.
• W4378981004 creator A5018474702 @default.
• W4378981004 creator A5020344479 @default.
• W4378981004 creator A5021264126 @default.
• W4378981004 creator A5022553664 @default.
• W4378981004 creator A5023635260 @default.
• W4378981004 creator A5025063054 @default.
• W4378981004 creator A5025723323 @default.
• W4378981004 creator A5027420799 @default.
• W4378981004 creator A5032477448 @default.
• W4378981004 creator A5032831124 @default.
• W4378981004 creator A5035261012 @default.
• W4378981004 creator A5039282180 @default.
• W4378981004 creator A5041977580 @default.
• W4378981004 creator A5042989547 @default.
• W4378981004 creator A5045083114 @default.
• W4378981004 creator A5045454738 @default.
• W4378981004 creator A5048540733 @default.
• W4378981004 creator A5049661977 @default.
• W4378981004 creator A5049882025 @default.
• W4378981004 creator A5050938952 @default.
• W4378981004 creator A5052922212 @default.
• W4378981004 creator A5053221956 @default.
• W4378981004 creator A5054617465 @default.
• W4378981004 creator A5057849200 @default.
• W4378981004 creator A5058075337 @default.
• W4378981004 creator A5058760175 @default.
• W4378981004 creator A5059367989 @default.
• W4378981004 creator A5060954139 @default.
• W4378981004 creator A5061095811 @default.
• W4378981004 creator A5068310472 @default.
• W4378981004 creator A5070139321 @default.
• W4378981004 creator A5071929183 @default.
• W4378981004 creator A5073135919 @default.
• W4378981004 creator A5073186349 @default.
• W4378981004 creator A5073507497 @default.
• W4378981004 creator A5076605844 @default.
• W4378981004 creator A5077424551 @default.
• W4378981004 creator A5078260129 @default.
• W4378981004 creator A5078839479 @default.
• W4378981004 creator A5081470600 @default.
• W4378981004 creator A5082916894 @default.
• W4378981004 creator A5083643384 @default.
• W4378981004 creator A5085172464 @default.
• W4378981004 creator A5085432815 @default.
• W4378981004 creator A5086876601 @default.
• W4378981004 date "2023-06-01" @default.
• W4378981004 modified "2023-09-24" @default.
• W4378981004 title "Data from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer" @default.
• W4378981004 doi "https://doi.org/10.1158/1078-0432.c.6675231.v1" @default.
• W4378981004 hasPublicationYear "2023" @default.
• W4378981004 type Work @default.
• W4378981004 citedByCount "0" @default.
• W4378981004 crossrefType "posted-content" @default.
• W4378981004 hasAuthorship W4378981004A5001343667 @default.
• W4378981004 hasAuthorship W4378981004A5004680827 @default.
• W4378981004 hasAuthorship W4378981004A5005250000 @default.
• W4378981004 hasAuthorship W4378981004A5007787317 @default.
• W4378981004 hasAuthorship W4378981004A5008719596 @default.
• W4378981004 hasAuthorship W4378981004A5008736570 @default.
• W4378981004 hasAuthorship W4378981004A5008894786 @default.
• W4378981004 hasAuthorship W4378981004A5011850347 @default.
• W4378981004 hasAuthorship W4378981004A5012176145 @default.
• W4378981004 hasAuthorship W4378981004A5013768705 @default.
• W4378981004 hasAuthorship W4378981004A5013913173 @default.
• W4378981004 hasAuthorship W4378981004A5016688954 @default.
• W4378981004 hasAuthorship W4378981004A5016711314 @default.
• W4378981004 hasAuthorship W4378981004A5018474702 @default.
• W4378981004 hasAuthorship W4378981004A5020344479 @default.
• W4378981004 hasAuthorship W4378981004A5021264126 @default.
• W4378981004 hasAuthorship W4378981004A5022553664 @default.
• W4378981004 hasAuthorship W4378981004A5023635260 @default.
• W4378981004 hasAuthorship W4378981004A5025063054 @default.
• W4378981004 hasAuthorship W4378981004A5025723323 @default.
• W4378981004 hasAuthorship W4378981004A5027420799 @default.
• W4378981004 hasAuthorship W4378981004A5032477448 @default.
• W4378981004 hasAuthorship W4378981004A5032831124 @default.
• W4378981004 hasAuthorship W4378981004A5035261012 @default.
• W4378981004 hasAuthorship W4378981004A5039282180 @default.
• W4378981004 hasAuthorship W4378981004A5041977580 @default.
• W4378981004 hasAuthorship W4378981004A5042989547 @default.
• W4378981004 hasAuthorship W4378981004A5045083114 @default.
• W4378981004 hasAuthorship W4378981004A5045454738 @default.
• W4378981004 hasAuthorship W4378981004A5048540733 @default.
• W4378981004 hasAuthorship W4378981004A5049661977 @default.
• W4378981004 hasAuthorship W4378981004A5049882025 @default.

• next